Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness*
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aimed to a) compare the efficacy of metoclopramide and erythromycin in the treatment of feed intolerance in critical illness; and b) determine the effectiveness of "rescue" combination therapy in patients who fail monotherapy. DESIGN: Randomized controlled trial. SETTING: Level III mixed medical and surgical intensive care unit. PATIENTS: Ninety mechanically ventilated, medical patients with feed-intolerance (gastric residual volume>or=250 mL). INTERVENTIONS: Patients received either metoclopramide 10 mg intravenously four times daily (n=45) or erythromycin 200 mg intravenously twice a day (n=45) in a double-blind, randomized fashion. After the first dose, nasogastric feeding was commenced and 6-hourly nasogastric aspirates were performed. If a gastric residual volume>or=250 mL recurred on treatment, open-label, combination therapy was given. Patients were studied for 7 days. Successful feeding was defined as 6-hourly gastric residual volume<250 mL with a feeding rate>or=40 mL/hr. MEASUREMENTS AND MAIN RESULTS: Demographic data, blood glucose levels, and use of inotropes, opioids, and benzodiazepines were similar between the two groups. After 24 hrs of treatment, both monotherapies reduced the mean gastric residual volume (metoclopramide, 830+/-32 mL to 435+/-30 mL, p<.0001; erythromycin, 798+/-33 mL to 201+/-19 mL, p<.0001) and improved the proportion of patients with successful feeding (metoclopramide=62% and erythromycin=87%). Treatment with erythromycin was more effective than metoclopramide, but the effectiveness of both treatments declined rapidly over time. In patients who failed monotherapy, rescue combination therapy was highly effective (day 1=92%) and maintained its effectiveness for the study duration (day 6=67%). High pretreatment gastric residual volume was associated with poor response to prokinetic therapy. CONCLUSIONS: In critical illness, erythromycin is more effective than metoclopramide in treating feed intolerance, but the rapid decline in effectiveness renders both treatments suboptimal. Rescue combination therapy is highly effective, and further study is required to examine its role as the first-line therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding
Chapman, M. J., Fraser, R. J., Kluger, M. T., Buist, M. D., & De Nichilo, D. J. (2000) · Critical Care Medicine · doi:10.1097/00003246-200007000-00026 · Cited by 163
Self-citationBerne, J. D., Norwood, S. H., McAuley, C. E., Vallina, V. L., Villareal, D., Weston, J., & McClarty, J. (2002) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200209000-00004 · Cited by 112
Erythromycin and early enteral nutrition in mechanically ventilated patients
Reignier, J., Bensaid, S., Perrin-Gachadoat, D., Burdin, M., Boiteau, R., & Tenaillon, A. (2002) · Critical Care Medicine · doi:10.1097/00003246-200206000-00012 · Cited by 101 · cited 2×
“Although a decline in the effectiveness of erythromycin has been reported in critically ill patients (18, 35), the rapid development of tachyphylaxis within the first 3 days of therapy in the current study was unexpected.”
BackgroundGastric feeding with erythromycin is equivalent to transpyloric feeding in the critically ill
Boivin, M. A., & Levy, H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200110000-00011 · Cited by 101 · cited 2×
“Although a decline in the effectiveness of erythromycin has been reported in critically ill patients (18, 35), the rapid development of tachyphylaxis within the first 3 days of therapy in the current study was unexpected.”
Background
Cited by
Nutrition in the acute phase of critical illness
Casaer, M. P., & Van den Berghe, G. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1304623 · Cited by 335
Lewis, K., Alqahtani, Z., Mcintyre, L., Almenawer, S., Alshamsi, F., Rhodes, A., Evans, L., Angus, D. C., & Alhazzani, W. (2016) · Critical Care · doi:10.1186/s13054-016-1441-z · Cited by 163
“Several studies suggest that erythromycin may be more effective than metoclopramide [52, 61].”
BackgroundAl-Dorzi, H. M., Albarrak, A., Ferwana, M., Murad, M. H., & Arabi, Y. M. (2016) · Critical Care · doi:10.1186/s13054-016-1539-3 · Cited by 74
“2 Chinese language [45, 50] 2 not in ICU setting [28, 48] 8 no difference in calories [30, 35-39, 42, 43] 1 parenteral nutrition contributed to high % of caloric intake [53] 3 cluster randomized trials [9, 10, 49] 8 no calorie data [27, 30, 34, 41, 44, 46, 47, 52] 2 no outcome data [31, 51] 1 observational study [33]…”
BackgroundInfluentialPeake, S. L., Davies, A. R., Deane, A. M., Lange, K., Moran, J. L., O’Connor, S. N., Ridley, E. J., Williams, P. J., & Chapman, M. J. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086322 · Cited by 71
“Emergency nonoperative 35 (61) 44 (80) Elective operative 11 (19) 6 (11)”
BackgroundInfluentialSelf-citationRidley, E. J., & Davies, A. R. (2011) · Nutrition · doi:10.1016/j.nut.2010.10.010 · Cited by 51
Metadata
- Authors
- Nguyen, N. Q., Chapman, M. J., Fraser, R. J., Bryant, L. K., & Holloway, R. H.
- Venue
- Critical Care Medicine
- Published
- 2007-02
- Volume
- 35
- Issue
- 2
- Pages
- 483-489
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2119212593
- Cited by
- 162
- References
- 4
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness*. https://app.cochat.ai/papers/10.1097/01.ccm.0000253410.36492.e9
- The paper
- Nguyen, N. Q., Chapman, M. J., Fraser, R. J., Bryant, L. K., & Holloway, R. H. (2007). Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000253410.36492.e9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.